Please ensure Javascript is enabled for purposes of website accessibility
Search
Accessibility Menu
Guardant Health Stock Quote

Guardant Health (NASDAQ: GH)

$26.16
(2.5%)
$0.64
Price as of May 28, 2024, 4:00 p.m. ET

Guardant Health Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
GH -6.84% -66.26% -19.53% -21%
S&P +27.79% +87.71% +13.41% +83%

Guardant Health Company Info

Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in Palo Alto, CA.

News & Analysis

The Fool has written over 100 articles on Guardant Health.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.